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Abstract
Objective: High rates of mental disorders have been reported for prison populations worldwide, particularly in low-
and middle-income countries (LMICs). The present study aimed to establish prevalence rates of mental disorders in
Chilean prisoners.
Method: A nationwide random sample of 1008 prisoners was assessed in 7 penal institutions throughout Chile.
Twelve-month prevalence rates were established using the Composite International Diagnostic Interview (CIDI) and
compared to the prevalence rates previously published for the general population.
Results: Prevalence rates were 12.2% (95% CI, 10.2-14.1) for any substance use disorder, 8.3% (6.6-10.0) for
anxiety disorders, 8.1% (6.5-9.8) for affective disorders, 5.7% (4.4-7.1) for intermittent explosive disorders, 2.2%
(1.4-3.2) for ADHD of the adult, and 0.8% (0.3-1.3) for non-affective psychoses. Significantly higher prevalence rates
among prisoners as compared to the general population in Chile were seen for major depression (6.1% vs. 3.7%
males, Z=2.58, p<0.05) and illicit drug use (3.3% vs. 0.6% males with drug abuse, Z=2.04, p<0.05; 2.6% vs. 0.1%
females with drug abuse, Z=5.36, p<0.001; 3.4% vs. 1.1% males with drug dependence, Z=3.70; p<0.001).
Dysthymia (6.5% vs. 15.6%, Z=-2.39, p<0.05), simple (3.3% vs. 11.5%, Z=-3.13, p<0.001) and social phobias (3.9%
vs. 9.7%, Z=2.38, p<0.05) were significantly less frequent in the female prison population than in the general
population. One-year prevalence rates of alcohol abuse (2.3% vs. 3.9%; Z=-2.04; p<0.05) and dependence (2.7% vs.
8.2%; Z=-5.24; p<0.001) were less prevalent in the male prison population than in the general population.
Conclusions: Service provision for prison populations in Chile should acknowledge high rates of depression and
illicit drug use. Overall prevalence rates are lower than reported in other LMICs. Previous research in prison
populations in LMICs might have overestimated prevalence rates of mental disorders.
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Introduction
There are about 10 million people worldwide in prisons at a
time [1]. The world prison population is growing by about one
million per decade [1]. In recent years, there has been growing
interest in the mental health of prison populations [2,3]. High
rates of mental disorders facing low treatment capacities have
given rise to concern. In several countries, special diversion
programmes were initiated to keep people with mental
disorders from being incarcerated [4]. They serve to reduce the
period of imprisonment of people with severe mental disorders
[5]. It is not yet clear whether high rates of people with mental
disorders in prisons are linked to reduced capacities of
institutionalized mental health care [6,7]. Criminal offenders
with mental disorders who do not undergo adequate treatment
may enter in a cycle of recidivism regarding both the mental
disorders and the criminal offenses [8,9]. Imprisonment may
constitute an opportunity to reach medically underserved
populations [10]. Services in prisons in Western high-income
countries are still not equivalent to those in the community and
reports suggest that they do not yet meet the mental health
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needs of the prisoners [11]. Neglected health needs of prison
inmates give rise to human rights concerns [12].
There has been a debate as to whether mental disorders are
on the rise within prison populations worldwide [2]. Systematic
reviews suggest that mental disorders are more prevalent in
prison populations than in the general population of the same
country [2]. Pooled prevalence rates of psychosis were
estimated to be 3.6% (95% CI 3.1-4.2) in male and 3.9% (95%
CI 2.7-5.0) in female prisoners. The prevalence rates of major
depression were estimated to be 10.2% (95% CI 8.8-11.7) in
male and 14.1% (95% CI 10.2-18.1) in female prisoners
worldwide. However, prevalence rates of prison populations
and the general population have not yet been systematically
compared within the same country. The majority of the world
prison population lives in low- and middle-income countries
(LMICs) [1]. Prevalence rates of mental disorders have only
been reported from 7 LMICs: Brazil [13], India [14], Iran [15],
Malaysia [16], Mexico [17], Nigeria [18,19] and South Africa
[20]. In the only review that has reported aggregated data from
LMICs, Kuwait and Dubai were also added to a group of LMICs
[2]. LMICs were estimated to have higher prevalence rates of
psychosis 5.5% (95% CI 4.2-6.8; p=0.035) than high-income
countries. However, some of the 7 studies from LMICs have
methodological shortcomings and some were conducted in
selective and small samples. Five of the 7 studies recruited the
samples from one single penal institution, one from two and
one from three penal institutions. Since the conditions vary
between the institutions, they may not be representative for the
penitentiary system of a country. One may conclude, that the
findings from those 7 studies may still be preliminary and
possibly inaccurate. Further methodologically sound studies
especially from LMICs are needed [2]. Penal institutions in
LMICs tend to be so poorly resourced that people with mental
disorders are at a particular risk of abuse and human rights
violations. It is therefore a question of ethical importance and
public health priority to study the type and frequency of mental
disorders in prison populations in LMICs so that calls for a
better allocation of resources for mental health care in prisons
can be underpinned with reliable data. The aim of the present
study was to establish prevalence rates of mental disorders in
the prison system in Chile and compare prevalence rates in
prison populations with those in the general population [21].
Methods
Ethics statement
The study was conducted in accordance with the Declaration
of Helsinki on ethical principles for medical research involving
human subjects. The Ministry of Justice of the Republic of
Chile approved of the study. The ethics committee and
institutional review board of the University of Chile approved of
the study (reference number 342/12). We used a standard
written informed consent procedure approved by the ethics
committee of the University of Chile. The inclusion of subjects
was voluntary upon written informed consent. The capacity of
giving informed consent was inferred from the capacity to
understand the information about the study and explain the
goals back to the interviewer. Age 15 or older and the capacity
to give written informed consent were inclusion criteria. Minors
of 15 to 17 years were subjected to the same informed consent
procedure as adults of 18 years and older. Relatives or
guardians were not involved in the written informed consent
procedure. All potential participants who declined or otherwise
did not participate were eligible for treatment as usual and were
not disadvantaged in any other way by not participating in the
study.
Design
We conducted a cross-sectional survey among 1008 of the
46,825 prisoners in closed correctional facilities in Chile. The
sample was recruited from 7 penal institutions located in 6
different cities and 5 regions of the country. The sample was
stratified for the 5 regions of the country (north, north-central,
central, south-central, south), proportionately to the size of the
prison population in each region.
Procedures
The participants were randomly selected from the 7 penal
institutions throughout Chile (located in Arica, Valparaíso, 2 in
Santiago, Rancagua, Concepción and Temuco). High security
sectors within the prisons for inmates showing uncooperative,
violent behaviours during detention or high numbers of daily
insurgencies were excluded for safety reasons. Sectors of
some of the penal institutions were excluded from the sampling
due to the lack of basic infrastructure such as a separate room
to conduct the interviews. Privacy of the information was
assured to all possible participants. All interviewees provided
written informed consent. The refusal rate was 1.0%. Two
medical doctors and one information technologist were trained
in using the Composite International Diagnostic Interview
(CIDI) in the Institute of Psychiatry Ramón de Fuentes in
Mexico, a WHO accredited centre. The team trained 28
interviewers in Chile for the fieldwork. The 28 trained
fieldworkers conducted the interviews between August and
October 2007. The field workers were selected on the basis of
being professionals with complete tertiary level education
related to the topic and setting of the study. They had different
professions such as social scientists, sociologists,
psychologists and social workers. All of the field workers were
trained in the use of the CIDI in a two-day workshop with
supervised practice interviews, role-plays and discussions of
each question. The trainers evaluated the interviewers’
understanding of the purpose of the study, the purpose of the
instrument and of the content of each question. Internal quality
control was assured through retraining and mentoring in the
field. Unannounced field visits supervising single interviews
were carried out. Weekly scheduled meetings with the
interviewers and field executives were held for problem
identification and troubleshooting.
Instruments
The interview schedule included socio-demographic
characteristics and a computerized version of the CIDI 3.0, a
fully structured lay administered interview to establish DSM-IV
diagnoses [22]. The instrument has a satisfactory concordance
with professionally administered interview schedules [23]. It
Mental Disorders in Chilean prisons
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has been shown that non-clinicians can reliably use the CIDI
after a relatively short training period [24]. The CIDI has shown
good to excellent Kappa coefficients in test–retest and
interrater reliability studies [24]. We opted for the 12-month
prevalence rates, rather than 30-day or lifetime prevalence
rates for its relevance regarding the need of treatment.
For the comparison of the prison and the general population,
we compared prevalence rates separately for males and
females. Data from the largest (n=2978), representative
population based survey in Chile conducted with the CIDI
(versions 1.0 and 1.1) in the 1990s was used for this
comparison [21]. Both age adapted and non-adapted
comparisons were made.
Analysis
Prevalence rates were calculated as per cent values with
95% confidence intervals with SPSS® statistical software
version 19. For the comparison of frequencies a two-sample
calculator for proportions with Stata® statistical software
version 12.0 was used. Z scores > ±1.96 and p values <0.05
were considered statistically significant corresponding to the
significance levels of the two-sided test.
Results
Socio-demographic characteristics
The final sample included 1008 inmates from five different
regions in the country (Table 1). The mean age of the sample
was 32.6 ± 10.1 years; 84.8% were male and 15.2% female.
There was information on the legal status of 877 subjects, of
which a majority of 79.6% were convicts and 20.4% pre-trial or
under trial detainees. About one fourth of the sample (25.8%)
had a total time in detention of less than 12 months. The mean
time spent in detention was 66.7 months. The mean number of
people per cell was 5.1 for the included subjects (Table 1).
Prevalence rates of mental disorders in Chilean prisons
The 12-month prevalence rate for any mental disorder was
26.6% (95% CI, 24.0-29.3). The prevalence rate for any
substance use disorder was 12.2% (95% CI, 10.2-14.1); within
that group 6.6% (95% CI, 5.2-8.1) of the total sample had
disorders associated with illicit drug use. The 12-month
prevalence rates for the group of anxiety disorders was 8.3%
(95% CI, 6.6-10.0), for the group of affective disorders 8.1%
(95% CI, 6.5-9.8); within that group 6.9% (95% CI, 5.4-8.6) had
major depressive disorders (Table 2).
Differences of prevalence rates for short and long term
prisoners
Subjects with a detention time ≤12 months had a higher rate
(35.7%) for any mental disorder than subjects with >12 months
in detention (23.1%; p<0.001; Table 3). Alcohol use disorders
were significantly more common (12.6%; 95% CI 8.5-16.7) in
inmates with a detention time ≤12 months as compared to
inmates with >12 months in detention (2.1%; 95% CI 1.1-3.1)
and illicit drug use disorders were more common for the
prisoners ≤12 months in detention (8.5%; 95% CI 5.1-11.9) as
compared to the ones >12 months in detention (3.5%; 95% CI
2.2-4.8). Since the reported data are 12-month prevalence
rates the latter numbers correspond to the ones reporting
continuous substance use during imprisonment. Nicotine
dependence was also significantly more common among those
with a detention time of less than 12 months. There was no
statistically significant difference for any of the other disorders.
Depression was more frequent in the ones with lower detention
time, mania more frequent among the ones with longer
detention time, but the differences were not statistically
significant.
Comparison of prevalence rates in the Chilean prison
population and general population
There were different patterns of mental disorders in the
prison population and the general population (Table 4):
Significantly higher prevalence rates among prisoners as
compared to the general population in Chile were seen for
major depression (6.1% vs. 3.7% males, Z=2.58, p<0.05) and
illicit drug use (3.3% vs. 0.6% males with drug abuse, Z=2.04,
p<0.05; 2.6% vs. 0.1% females with drug abuse, Z=5.36,
p<0.001; 3.4% vs. 1.1% males with drug dependence, Z=3.70;
p<0.001). To the contrary, dysthymia (6.5% vs. 15.6%,
Z=-2.39, p<0.05), simple (3.3% vs. 11.5%, Z=-3.13, p<0.001)
Table 1. socio-demographic characteristics of the sample.
Sample size  n=1008
Gender   
 Male 84.8% (n=855)
 Female 15.2% (n=153)
Age Mean 32.6 ± 10.1 years
 15-24 years 24.8% (n=250)
 25-34 years 36.9% (n=372)
 35-44 years 25.5% (n=257)
 45-54 years 9.4% (n=95)
 55-64 years 2.9% (n=29)
 >65 years 0.5% (n=5)
Legal status (n=877)   
 Convicts 79.6% (n=698)
 Pre-trial detainees 20.4% (n=179)
Total time in detention
(n=990) Mean 58.4 (95% CI; 54.7-62.1)
≤12 months total time in
detention (n=990)  25.8% (n=255)
>12 months total time in
detention (n=990)  74.2% (n=735)
Number of people sharing
the same cell Mean 5.1 (95% CI; 4.7-5.7)
Location   
 North (Arica) 15.2% (n=153)
 North-central (Valparaíso) 11.2% (n=116)
 Central (Santiago) 36.9% (n=372)
 South-central (Rancagua,Concepción) 22.9% (n=231)
 South (Temuco) 13.5% (n=136)
Mental Disorders in Chilean prisons
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and social phobias (3.9% vs. 9.7%, Z=2.38, p<0.05) were
significantly less frequent in the female prison populations than
in the general population. One-year prevalence of alcohol
abuse (2.3% vs. 3.9%; Z=-2.04; p<0.05) and dependence
(2.7% vs. 8.2%; Z=-5.24; p<0.001) were less prevalent in the
male prison population than in the general population. There
was a trend for higher rates of non-affective psychosis in the
prison population (p<0.1 for the two-sided z-test; if presuming
higher rates in the prison population and performing the one-
sided z-test, significance levels of <0.05 would have been
reached). When the data was weighted for age, the differences
remained significant for the same categories.
Co-morbidity
Co-morbidity rates are reported for the two most important
diagnostic categories, major depression and illicit drug use
disorders. Most frequent co-morbid diagnoses in people with
illicit drug use (n= 70) were anxiety disorders and intermittent
explosive disorder with 16.7% (95% CI 7.7-25.8) each.
Affective disorders were co-morbid in 12.1% (95% CI 4.3-19.9)
and ADHD in 10.6% (95% CI 3.2-18.0) of the people with illicit
drug use. People with major depressive disorders (n= 67) had
most commonly comorbid anxiety disorder (43.5%; 95% CI
31.9-55.8), substance use disorders (22.8%; 95% CI
13.3-33.1), intermittent explosive disorder (18.9%; 95% CI
9.7-28.1) and ADHD (7.2%; 95% CI 1.1-13.3).
Discussion
As compared to the general population, prisoners in Chile
had higher prevalence rates for illicit drug use disorders and
major depression. Anxiety disorders in female prisoners and
alcohol use disorders in male prisoners were less frequent than
in the general population. Prisoners with less than one-year
detention time had higher one-year prevalence rates of
substance use disorders than prisoners with more than one
year in detention. Regarding the co-occurrence of mental
disorders, major depression had high rates of co-morbidity.
Overall, the prevalence rates for mental disorders identified in
Chilean prisons in this study are lower than the estimates for
other low- and middle-income countries [2].
Strengths and limitations
This is the largest and most systematic prevalence study of
mental disorders in prison populations from a non-Western
middle-income country using a standardized structured
interview to generate diagnoses. It is the first study that
compares nationwide data from prison populations with
nationwide data from a population based study, which both
used the same standardized interview schedule. A limitation for
the comparison of the prevalence data between the prison
population and the general population arises from a time lag of
8-15 years between the two studies. The prevalence data in
the general population might have changed over time.
As in most prison mental health studies, there were specific
challenges regarding the sampling. We had to exclude high
security sectors and prisoners with violent or uncooperative
behaviours to assure the safety of the fieldworkers. We also
excluded sectors within the prisons that were so poorly
resourced that they could not provide the infrastructure
Table 2. Prevalence rates of mental disorders in Chilean
prison populations.
Group Disorder Phenomenon
Prevalence
rate
95%
Confidence
interval
Any mental
disorder   26.6% (24.0-29.3)
Substance
use disorder   12.2% (10.2-14.1)
 Illicit drug usedisorder  6.6% (5.2-8.1)
  Abuse 3.2% (2.1-4.4)
  Dependence 3.5% (2.4-4.7)
 Alcohol usedisorder  4.7% (3.4-5.9)
  Abuse 2.1% (1.2-3.0)
  Dependence 2.6% (1.6-3.6)
 Nicotine usedisorder Dependence 4.4% (3.2-5.8)
Affective
disorders   8.1% (6.5-9.8)
 Major depression  6.9% (5.4-8.6)
 Minor depression  0.4% (0.1-0.8)
 Dysthymia  1.1% (0.5-1.8)
 Mania  1.3% (0.7-2.0)
Anxiety
disorders   8.3% (6.6-10.0)
 Generalisedanxiety disorder  0.8% (0.3-1.4)
 Simple phobia  3.1% (2.0-4.2)
  Agoraphobia 0.4% (0.1-0.8)
 Social phobia  3.2% (2.3-4.4)
 Panic disorder  1.2% (0.6-1.9)
 Adult separationanxiety disorder  2.5% (1.6-3.5)
 PTSD  1.1% (0.5-1.8)
 
Obsessive
compulsive
disorder
 0.2%  
Other
disorders   7.2% (5.7-8.9)
 ADHD of theadult  2.2% (1.4-3.2)
 
Intermittent
explosive
disorder
 5.7% (4.4-7.1)
 Anorexia  0  
 Bulimia  0.1%  
 Pathologicalgambling  0  
Possible non-
affective
psychosis
  0.8% (0.3-1.3)
Mental Disorders in Chilean prisons
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required to implement the study such as an interview room.
Even though treatment capacities for prison inmates were still
extremely low at the time of the study, we cannot exclude that
few subjects were successfully treated because we did not
collect information on current medication or treatment.
Comparison against the literature
There are several limitations for the comparison with studies
from other countries: 1. The sampling, as explained above,
may have been selective for prisoners with cooperative
behaviours. It can be assumed most prison mental health
studies are limited in reaching prisoners with violent,
dangerous or uncooperative behaviours. 2. Other studies may
refer to lifetime or current prevalence rates rather than the 12-
month prevalence rates used in this study. 3. Different studies
applied different structured psychometric instruments to
generate the diagnoses. An alternative to the CIDI used in our
study is the Structured Clinical Interview for DSM-axis I and II
(SCID I and II) used by other groups for studying prevalence
rates in prison populations [25]. The SCID has the advantage
over the CIDI that it includes diagnoses of several personality
disorders if both parts are applied. It may produce a higher
level of diagnostic accuracy, because it is professionally
administered. At the same time, this is a disadvantage for
poorly resourced settings. Several recently published prison
mental health studies used the Mini International
Neuropsychiatric Interview [13,20,26], which is similarly to the
CIDI a fully structured lay administered interview schedule. It
has the advantage that its use is easier to train and teach, it is
quicker to administer and it has a section for the detection of
antisocial personality disorder, which is relevant for prison
populations [27]. For international comparisons of prevalence
data, consistent instruments and equivalent time spans should
be used (e.g. point prevalence, one-year prevalence or life-time
prevalence).
Despite these limitations and the heterogeneous findings of
the previous 7 studies from LMICs, our results should be seen
against the background of other studies: In comparison, the
prevalence rates of mental disorders reported here are lower
[13,15]. A study in the closed correctional system of Brazil
reported rates of 17.6% for lifetime depression, 5.2% for
current depression, 6.6% for lifetime bipolar disorder, 26.6% for
lifetime alcohol addiction, 27.9% for lifetime drug addiction, and
1.4% for psychotic disorders [13]. Data reported from India
were part of an intervention study including mainly pre-trial
detainees. Prior to the intervention, prisoners in two jails were
screened for severe mental disorders (psychosis and mood
disorders) and a 10% prevalence rate was found [14]. A study
from Iran reported 3.1% current and 3.9% lifetime prevalence
for psychotic disorders, 30.6% current and 48.7% lifetime
prevalence for mood disorders, 11.2% current and 78.0%
lifetime prevalence for substance use disorders. Different low-
and middle-income countries present different legal and
cultural frameworks. Iran employs, as other Middle-Eastern
countries, strict laws on substance use, which may explain in
part that very high rates of substance use problems were found
in the prison population. Rates of current psychotic and mood
disorders were also higher than the 12-month prevalence rates
found in our study [15]. A prison mental health survey
Table 3. Prevalence rates of prisoners with ≤12 and >12
months of time in detention.
 Prison Population (n=990)  
 
≤12 months in detention
(n=255)
>12 months in detention
(n=735)
Two-sample
z-test of
proportions
Disorder
Prevalence
rate 95% CI
Prevalence
rate 95% CI  
Any disorder 35.7% (29.8-42.0) 23.1% (20.1-26.0) Z=3.94**
Any affective
disorder 9.0% (5.5-12.9) 7.6% (5.7-9.5) Z=0.71
n.s.
Major
depressive
episode
8.2% (5.1-12.1) 6.4% (4.6-8.2) Z=0.98n.s.
Dysthymia 0.4% (0.0-1.2) 1.2% (0.5-2.0) Z=-1.11n.s.
Mania 0.0%  1.4% (0.5-2.2) Z=-1.68n.s.
Anxiety
disorder 8.2% (5.1-11.8) 8.3% (6.4-10.2) Z=-0.05
n.s.
Generalized
anxiety
disorder
1.2% (0.0-2.7) 0.7% (0.1-1.2) Z=0.76n.s.
Simple
phobia 3.9% (1.6-6.7) 2.9% (1.8-4.1) Z=0.97
n.s.
Agoraphobia 0.0  0.5% (0.1-1.1) Z=-0.71n.s.
Social phobia 3.1% (1.2-5.5) 3.0% (1.8-4.4) Z=0.08n.s.
Panic
disorder 0.4% (0.0-1.2) 1.5% (0.7-2.4) Z=-1.29
n.s.
Post-
traumatic
stress
disorder
0.4% (0.4-1.2) 1.4% (0.7-2.2) Z=-0.94n.s.
Any
substance
use disorder
22.7% (17.6-28.2) 8.7% (6.7-11.0) Z=5.86**
Alcohol abuse 6.3% (3.5-9.4) 0.7% (0.1-1.4) Z=5.32**
Alcohol
dependence 6.3% (3.5-9.4) 1.4% (0.5-2.2) Z=4.19
**
Illicit drug
abuse 5.1% (2.4-7.8) 2.4% (1.5-3.5) Z=2.14
*
Illicit drug
dependence 3.4% (2.3-4.8) 1.1% (0.6-1.8) Z=2.45
*
Nicotine
dependence 8.2% (5.1-11.8) 1.9% (1.0-3.0) Z=4.70
**
Possible non-
affective
psychosis
1.2% (0.7-2.7) 0.5% (0.0-1.1) Z=1.17n.s.
Intermittent
explosive
disorder
7.1% (3.9-10.2) 5.0% (3.5-6.7) Z=1.26n.s.
Attention
deficit
disorder
2.4% (0.8-4.3) 2.2% (1.1-3.3) Z=0.19n.s.
n s. not significant
*. p<0.05
**. p<0.001
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conducted in Malaysia primarily targeted HIV positive prisoners
and the comorbidity of HIV, mental and substance use
disorders [16]. A study from Mexico on mental disorders of
female prisoners showed a prevalence rate of 62% for
depression in a selective sample with a history of a substance
use disorder [17]. The study from Nigeria in 100 inmates
reported a lifetime prevalence of 25% for substance use
disorders. Two cases of schizophrenia, two cases of major
depression and twenty-one cases of recurrent mild depression
were in the sample [18]. The most recently published prison
mental health survey from South Africa reported that 42% had
a substance use disorder, 10.4% current major depression,
24.9% lifetime depression, 4.7% current psychosis and 7.3%
lifetime prevalence of psychosis [20]. Especially current non-
affective psychotic episodes may have been overestimated by
previous research. Apart from a general difficulty to some
diagnoses, especially current active schizophrenia, with
diagnostic structured interviews, the different interview
schedules may have different thresholds for producing positive
scores [28].
Even as compared to high-income countries the prevalence
rates found in our study appear to be low [2]. In a sample of
long-term prisoners in Sweden, 40% of the participants were
estimated to have ADHD as compared to 2.2% in our sample
[29]. There are several possible explanations for the moderate
prevalence rates: 1. Chile has 305 prisoners per 100,000
population, one of the highest prison population rates in Latin
America [1], more than double of the worldwide and South
American averages. As for many other countries, the prison
population in Chile has more than doubled since 1992 [30].
When prison population rates are very high, the prison
population may be more similar to the general population
regarding their mental health than in countries with lower prison
population rates.
Table 4. Comparison of the prevalence rates between the prison population and the general population, presented
separately for males and females.
 Male  Female  
 Prison population (n=855) General population[21]
Two-sample z-
test of
proportions Prison population (n=153)General population[21]
Two-sample z-
test of
proportions
Disorder
Prevalence
rate 95% CI
Prevalence
rate 95% CI  
Prevalence
rate 95% CI
Prevalence
rate 95% CI  
Any affective
disorder 7.6% (5.9-9.6) 5.7% (4.5-7.1) Z=1.75
n.s. 11.1% (6.6-17.2) 12.6% (11.1-14.3) Z=-0.54n.s.
Major depressive
episode 6.1% (4.9-7.9) 3.7% (2.7-4.8) Z=2.58
* 11.1% (6.6-17.2) 7.5% (6.3-8.8) Z=1.59n.s.
Dysthymia 1.1% (0.5-2.2) 1.6% (1.0-2.5) Z=-0.96n.s. 1.3% (0.2-4.6) 5.9% (4.8-7.1) Z=-2.39*
Mania 1.4% (0.7-2.4) 0.7% (0.3-1.3) Z=1.61n.s. 0.7% (0.0-3.6) 2.1% (1.5-2.9) Z=-1.19n.s.
Anxiety disordera 4.3% (3.5-5.7) 3.7% (2.7-4.8) Z=0.70n.s. 6.5% (3.3-10.5) 15.6% (14.0-17.6) Z=-3.03*
Generalized anxiety
disorder 0.9% (0.4-1.8) 0.7% (0.3-1.3) Z=0.51
n.s. 0.0%  1.1% (0.4-1.8) Z=-1.30n.s.
Simple phobia 3.0% (2.0-4.4) 3.8% (2.8-5.0) Z=-0.99n.s. 3.3% (3.1-7.5) 11.5% (10.0-13.1) Z=-3.13**
Social phobia 3.0% (2.0-4.4) 2.5% (1.7-3.5) Z=0.70n.s. 3.9% (1.5-8.3) 9.7% (8.4-11.2) Z=-2.38*
Obsessive-
compulsive disorder 0.2% (0.0-0.5) 0.7% (0.2-1.2) Z=-1.6
n.s. 0.0%  1.6% (1.0-2.2) Z=-1.58n.s.
Post-traumatic
stress disorder 0.7% (0.3-1.5) 1.1% (0.6-1.8) Z=-0.94
n.s. 3.3% (3.1-7.5) 2.4% (1.7-3.3) Z=0.69n.s.
Any substance use
disorder 12.9% (10.9-15.2) 14.4% (12.5-16.3) Z=-0.98
n.s. 8.5% (4.6-13.1) 6.7% (5.5-7.9) Z=0.84n.s.
Alcohol abuse 2.3% (1.4-3.4) 3.9% (2.9-5.1) Z=-2.04* 0.7% (0.0-2.0) 0.8% (0.5-1.4) Z=-0.13n.s.
Alcohol dependence 2.7% (1.7-4.0) 8.2% (6.8-9.8) Z=-5.24** 2.0% (0.4-5.6) 1.4% (0.9-2.1) Z=0.59n.s.
Illicit drug abuse 3.3% (2.1-4.6) 0.6% (0.3-1.2) Z=2.04* 2.6% (0.7-5.2) 0.1% (0.0-0.4) Z=5.36**
Illicit drug
dependence 3.4% (2.3-4.8) 1.1% (0.6-1.8) Z=3.70
** 3.9% (1.5-8.3) 2.0% (1.4-2.8) Z=1.55n.s.
Nicotine
dependence 4.9% (3.5-6.3) 2.9% (2.0-3.8) Z=2.39
* 1.3% (0.0-3.3) 3.1% (2.3-3.9) Z=-1.26n.s.
Possible non-
affective psychosis 0.7% (0.3-1.5) 0.2% (0.0-0.7) Z=1.79
n.s. 1.3% (0.2-4.6) 1.1% (0.7-1.7) Z=0.23n.s.
a. anxiety disorders without social phobia and obsessive-compulsive disorders
n s. not significant
*. p<0.05
**. p<0.001
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2. There was a majority of long term convicts in our sample
who show lower rates especially of substance use disorders
than recently admitted prisoners. Levels of distress may be
highest shortly after admission because of adaptation to the
adverse conditions of imprisonment over time. Reduced rates
of overall mental disorders were found in a longitudinal study of
the effects of long-term imprisonment in a Western setting
including a stabilization of pathological personality traits [31].
Imprisonment may hinder use of drugs and alcohol, but does
not preclude it since these substances are still available.
However, the type of abuse may be different in and outside of
prisons. Our data indicate that it is more common to maintain
illicit drug use than alcohol use. That is in line with reports from
prison inmates about illicit drug dependence inside the
institution, whereas it is more unusual to maintain alcohol
dependence [32]. There may also be a reporting bias in the
sense of underreporting of active substance use inside the
prison. Our data underline the weight the penal institutions
have regarding the institutionalization of people with substance
use disorders. This window of opportunity should be used for
the care of those disorders. Even though our study was not
longitudinal the results give indirect evidence that prison
inmates reduce active substance use to a certain degree
during imprisonment. This may neither be sustainable beyond
the sentence nor a cost effective way to deal with addiction nor
humane but it constitutes a reality for many people affected by
substance use disorders. Inmates show high rates of relapse
and death from overdose after release from prison [33].
There are two possible explanations for the lower rates of
simple and social phobia in the female prison population as
compared to the general population: 1. Simple and social
phobia may be associated with traits that are protective against
engaging in criminal behaviour. 2. Imprisonment may constitute
a protective environment characterized by monotony,
predictability and avoidance of possible trigger situations for
simple and social phobia.
Conclusions
The findings are not consistent with the hypothesis that
severe mental disorders are generally more prevalent in prison
populations of low- and middle-income countries than in high-
income countries [2]. Previous studies might have
overestimated the prevalence of severe mental disorders in
LMIC prisons. At the same time, the differences with other
findings might also be linked to specific aspects of the context
in Chile.
Illicit drug use disorders and major depression may be the
most urgent mental health problems to consider when scaling
up services for prison populations in Chile with markedly
elevated rates as compared to the general population and high
rates of co-morbidity. Intervention programmes should focus on
prisoners with short term sentences since they have higher
prevalence rates and provide the chance of initiating treatment.
Qualitative studies may complete the picture on how people
with severe non-affective psychosis are dealt with in prisons in
Chile and other LMICs. Other studies using different sampling
strategies should provide data on mental disorders shortly after
admission and of prisoners with short but possibly recurrent
sentences. With respect to research in prison populations in
general, the results underline that further studies should
distinguish between short and long term prisoners since the
mental health problems are likely to be different.
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